Wendong Yu, M.D., Ph.D.
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Wendong Yu
I am a Pathologist with special interests in Bone and Soft Tissue Pathology, and Cytopathology. I love the art and science of Pathology, enjoy sharing my passion and knowledge with trainees, and understands the increasingly critical roles of Pathology in patient care. Besides clinical services, I am also involved in cytologist education as Executive Advisor for the Cytotechnology program in the School of Health Professions, and various developing projects as Division Representative for Houston Area Locations (HALs) and Medical Director of Anatomic Pathology for West Houston Diagnostic Imaging laboratory. My research includes the clinical utility of Mass Spectrometry imaging, morphologic, immunohistochemical, and molecular studies of various bone and soft tissue tumors, and HPV in head and neck tumors.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1997 | Weifang Medical University, Weifang, CHN, MD, Clinical Medicine |
Postgraduate Training
| 2014-2015 | Clinical Fellowship, Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2012-2013 | Chief Resident, Anatomic and Clinical Pathology, University of Miami /Jackson Memorial Hospital, Miami, FL |
| 2010-2014 | Clinical Residency, Anatomic and Clinical Pathology, University of Miami /Jackson Memorial Hospital, Miami, FL |
Board Certifications
| 2015 | American Board of Pathology Cytopathology |
| 2014 | Anatomic and Clinical Pathology |
Selected Publications
Peer-Reviewed Articles
- Zhang J, Li SQ, Lin JQ, Yu W, Eberlin LS. Mass Spectrometry Imaging Enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues. Cancer Res 80(4):689-698, 2020. e-Pub 2019. PMID: 31843980.
- DeHoog RJ, Zhang J, Alore E, Lin JQ, Yu W, Woody S, Almendariz C, Lin M, Engelsman AF, Sidhu SB, Tibshirani R, Suliburk J, Eberlin LS. Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies. Proc Natl Acad Sci U S A 116(43):21401-21408, 2019. e-Pub 2019. PMID: 31591199.
- Zhang J, Rector J, Lin JQ, Young JH, Sans M, Katta N, Giese N, Yu W, Nagi C, Suliburk J, Liu J, Bensussan A, DeHoog RJ, Garza KY, Ludolph B, Sorace AG, Syed A, Zahedivash A, Milner TE, Eberlin LS. Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system. Sci Transl Med 9(406), 2017. PMID: 28878011.
- Zhang J, Yu W, Ryu SW, Lin J, Buentello G, Tibshirani R, Suliburk J, Eberlin LS. Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors. Cancer Res 76(22):6588-6597, 2016. e-Pub 2016. PMID: 27659048.
- Wang J, Yu W, Cai Y, Ren C, Ittmann MM. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression. Neoplasia 10(8):847-56, 2008. PMID: 18670643.
- Yu W, Wang Y, Shaw CA, Qin XF, Rice AP. Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. Retrovirology 3:32, 2006. e-Pub 2006. PMID: 16764723.
Patient Reviews
CV information above last modified May 30, 2024